Roche to repurchase equity stake held by Novartis
Roche and Novartis agree on the repurchase by Roche Holding…
Roche and Novartis agree on the repurchase by Roche Holding Ltd of 53.3 million shares from Novartis worth 19 billion Swiss francs (CHF).
List view / Grid view
Roche and Novartis agree on the repurchase by Roche Holding…
Roche and Novartis agree on the repurchase by Roche Holding Ltd of 53.3 million shares from Novartis worth 19 billion Swiss francs (CHF).
Roche announced that its Ordinary Annual General Meeting has voted…
4 March 2014 | By Roche
Roche announced that its Ordinary Annual General Meeting has voted in favour of all of the Board of Directors’ proposals...
Roche’s CEO Severin Schwan: “2013 was a very good year…
30 January 2014 | By Roche
Roche’s CEO Severin Schwan: “2013 was a very good year for Roche. We exceeded our financial targets with strong demand for our existing products and positive uptake of recently launched medicines and diagnostics...
At the forthcoming Annual Shareholders Meeting on 4 March 2014,…
16 September 2013 | By Roche
At the forthcoming Annual Shareholders Meeting on 4 March 2014, the Roche Board of Directors will propose Christoph Franz to be elected as Chairman of the Board.